These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12858325)

  • 1. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
    Dalery J; Honig A
    Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
    Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
    J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
    Sechter D; Troy S; Paternetti S; Boyer P
    Eur Psychiatry; 1999 Mar; 14(1):41-8. PubMed ID: 10572324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J; Keegstra H; Barrelet L
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
    Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study.
    Novotny V; Faltus F
    Hum Psychopharmacol; 2002 Aug; 17(6):299-303. PubMed ID: 12404675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine.
    Uzunova V; Sheline Y; Davis JM; Rasmusson A; Uzunov DP; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3239-44. PubMed ID: 9501247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA
    Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.
    Zhou J; Wang X; Feng L; Xiao L; Yang R; Zhu X; Shi H; Hu Y; Chen R; Boyce P; Wang G
    BMC Psychiatry; 2021 May; 21(1):260. PubMed ID: 34011310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB; Spillmann MK; Kolsky AR; Alpert JE; Nierenberg AA; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Nemeroff CB; Entsuah R; Benattia I; Demitrack M; Sloan DM; Thase ME
    Biol Psychiatry; 2008 Feb; 63(4):424-34. PubMed ID: 17888885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E; Koran LM; Goodman WK; Greist JH; Ninan PT; Yang H; Li D; Barbato LM
    J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
    Bennie EH; Mullin JM; Martindale JJ
    J Clin Psychiatry; 1995 Jun; 56(6):229-37. PubMed ID: 7775364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on sertraline in the management of major depressive disorder in elderly patients.
    Muijsers RB; Plosker GL; Noble S
    CNS Drugs; 2002; 16(11):789-94. PubMed ID: 12383038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients.
    Katoh Y; Uchida S; Kawai M; Takei N; Mori N; Kawakami J; Kagawa Y; Yamada S; Namiki N; Hashimoto H
    Biol Pharm Bull; 2010; 33(12):1999-2002. PubMed ID: 21139240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.